- Company News
- Corporate Finance
- Equity Research
- In Media
- M&A Know-how
- Macro and markets
- Market Snapshots
Since the beginning of this month, Nico Schmidt-Weidemann has become part of the partner team at CatCap and will be responsible for advising clients in the sectors: consumer goods and life sciences. Nico Schmidt-Weidemann has been with CatCap for three years and during this time was involved in a number of successful transactions in the German-speaking area from the Munich location. This included the recent sale of water park manufacturer Wibit to Argos Wityu. As a partner in the Munich office of CatCap, he will continue to focus on M&A activities in the DACH region in the future.
Nico Schmidt-Weidemann graduated with a LL.M (M&A) from the Frankfurt School of Finance & Management. He began his career at the French banking group Natixis with stops in New York, Paris and Frankfurt. There he accompanied numerous cross-border transactions of German and French companies.
The increase of employees is part of CatCap’s growth and internationalization strategy, which has recently broadened the range of services for its clients through the acquisition of the advisory activities of Dansk Merchant Capital, including the team led by Anders Bo and Flemming C. Pedersen in Copenhagen.
“We are pleased to welcome a colleague with such extensive expertise and diverse experience in cross-border transactions in our circle of partners. Through the promotion, we again focus on the further development of our talents”, emphasizes Caspar Graf Stauffenberg, Managing Partner of CatCap in Munich.
Nico Schmidt-Weidemann: “CatCap has developed very well in recent years and I am pleased to be part of this dynamic development.”
Mark Miller and Michael Moritz, Managing Partners of CatCap in Hamburg and Berlin:”We are very pleased that we were able to partner with Nico Schmidt-Weidemann after many years of successful work at CatCap. With Nico Schmidt-Weidemann, we have further strengthened our competence in the segments: Consumer and Life Sciences.”